SWS Medical(SH:688410) 2 1 Shi Ji Jing Ji Bao Dao·2026-01-30 07:45Core Viewpoint - The company expects a significant increase in net profit for 2025, with projections indicating a growth of 98.00% to 125.00% year-on-year, driven by its leading position in the domestic blood purification equipment market and enhanced sales of self-produced consumables [1] Group 1: Financial Projections - The projected net profit attributable to shareholders for 2025 is estimated to be between 140 million to 159 million yuan [1] - The projected net profit excluding non-recurring gains and losses is expected to be between 134 million to 154 million yuan, reflecting a year-on-year increase of 135.00% to 170.00% [1] Group 2: Business Drivers - The company's leading position in the blood purification equipment sector, supported by technological advantages and strong brand effects, has led to an increase in market share and steady growth in sales revenue [1] - There has been a significant increase in sales revenue from self-produced blood purification consumables during the reporting period [1] - The rise in production and sales volume has resulted in a decrease in fixed costs per unit for self-produced consumables, leading to an improvement in gross profit margin and overall profitability [1]